跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE
Authorized
STANDARD
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE
Apotex Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
e2cd4e401e471d86
Company
Apotex Inc
Type
Standard
Approval Details
Approval Id
e2cd4e401e471d86
Drug Approval Canada Name
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE
Product Name
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE
Status
Marketed
Status Date
2022-11-07
Original Market Date
2022-11-07
Din
02509415
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
68:20.05
Atc Original
A10BD07 METFORMIN AND SITAGLIPTIN
Atc Name
a 10 bd 07
Aig Number
0252656001
Company Name
Apotex Inc
Company Address
150 Signet Drive, Toronto, Ontario, Canada, M9L 1T9
Company Detail Path
/organization/apotex-inc
Company Information
Pharmaceutical Company Name
Apotex Inc
Country Name
Canada
Province Name
Ontario
City Name
toronto,ontario,country_ca
Address
150 Signet Dr
Active Ingredients
METFORMIN HYDROCHLORIDE
500 MG
SITAGLIPTIN (SITAGLIPTIN MALATE)
50 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
e2cd4e401e471d86
Type
Standard
Back to Health Canada Approvals
APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE - Health Canada Drug Approval Details
